Japan Generics Market Summary, Competitive Analysis and Forecast to 2027

Japan Generics Market Summary, Competitive Analysis and Forecast to 2027


Summary

Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
  • The Japanese generics market had total revenues of $15.0 billion in 2022, representing a compound annual growth rate (CAGR) of 14.3% between 2017 and 2022.
  • Market consumption volume increased with a CAGR of 7% between 2017 and 2022, to reach a total of 56.4% in 2022.
  • The mounting aging population in the country is boosting healthcare costs, as a result, the Ministry of Health, Labor, and Welfare (MHLW) promotes the usage of generic drugs as these are much more affordable.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Japan
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Japan
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Japan generics market with five year forecasts by both value and volume
Reasons to Buy
  • What was the size of the Japan generics market by value in 2022?
  • What will be the size of the Japan generics market in 2027?
  • What factors are affecting the strength of competition in the Japan generics market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Japan's generics market?


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Have there been any recent developments in the market?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Daiichi Sankyo Co Ltd
8.3. Sawai Pharmaceutical Co Ltd
8.4. Viatris Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Japan generics market value: $ million, 2017-22
Table 2: Japan generics market volume: %, 2017-22
Table 3: Japan generics market geography segmentation: $ million, 2022
Table 4: Japan generics market value forecast: $ million, 2022-27
Table 5: Japan generics market volume forecast: %, 2022-27
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Daiichi Sankyo Co Ltd: key facts
Table 10: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 11: Daiichi Sankyo Co Ltd: Key Employees
Table 12: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 13: Sawai Pharmaceutical Co Ltd: key facts
Table 14: Sawai Pharmaceutical Co Ltd: Key Employees
Table 15: Viatris Inc.: key facts
Table 16: Viatris Inc.: Annual Financial Ratios
Table 17: Viatris Inc.: Key Employees
Table 18: Viatris Inc.: Key Employees Continued
Table 19: Japan size of population (million), 2018-22
Table 20: Japan gdp (constant 2005 prices, $ billion), 2018-22
Table 21: Japan gdp (current prices, $ billion), 2018-22
Table 22: Japan inflation, 2018-22
Table 23: Japan consumer price index (absolute), 2018-22
Table 24: Japan exchange rate, 2018-22
List of Figures
Figure 1: Japan generics market value: $ million, 2017-22
Figure 2: Japan generics market volume: %, 2017-22
Figure 3: Japan generics market geography segmentation: % share, by value, 2022
Figure 4: Japan generics market value forecast: $ million, 2022-27
Figure 5: Japan generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the generics market in Japan, 2022
Figure 7: Drivers of buyer power in the generics market in Japan, 2022
Figure 8: Drivers of supplier power in the generics market in Japan, 2022
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Japan, 2022
Figure 10: Factors influencing the threat of substitutes in the generics market in Japan, 2022
Figure 11: Drivers of degree of rivalry in the generics market in Japan, 2022

Loading...

In this report,

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings